Examkin

Question

Difficulty: HardPediatric Cardiovascular Disorders

A 5-month-old boy is brought to the emergency department by his parents due to a persistent fever for the past 6 days. His mother reports he has been extremely irritable, feeding poorly, and has a mild, dry cough. A transient erythematous macular rash was noted on his trunk 3 days ago but has since resolved. His temperature is 39.8°C (103.6°F), heart rate is 175/min, blood pressure is 85/50 mmHg, and respiratory rate is 45/min. On physical examination, the infant is fussy but consolable. He has bilateral non-exudative conjunctival injection and erythematous, cracked lips. There is no cervical lymphadenopathy, and his hands and feet appear normal without edema or peeling. Breath sounds are clear bilaterally. Cardiac examination reveals a tachycardic, regular rhythm with no murmurs. Laboratory studies reveal:

Laboratory TestResultReference Range
Hemoglobin10.2 g/dL10.5 - 14.0 g/dL
Leukocytes18,500/mm³ (78% neutrophils)6,000 - 15,000/mm³
Platelets580,000/mm³150,000 - 450,000/mm³
Erythrocyte sedimentation rate85 mm/hr0 - 20 mm/hr
C-reactive protein120 mg/L< 10 mg/L

Urinalysis demonstrates 25 leukocytes/hpf, negative nitrites, and no bacteria. Which of the following is the most appropriate next step in the management of this patient?

  1. Administer intravenous immunoglobulin and high-dose aspirinAnswer
  2. B
    Initiate intravenous ceftriaxone for a presumed urinary tract infection
  3. C
    Administer nebulized albuterol and oral dexamethasone
  4. D
    Discharge with antipyretics and reassure regarding a benign viral exanthem
  5. E
    Refer for early intervention services due to acute developmental regression

Answer

The most appropriate next step in management is to administer intravenous immunoglobulin (IVIG) and high-dose aspirin to treat incomplete Kawasaki disease and prevent coronary artery aneurysms.
This 5-month-old infant presents with prolonged fever (≥ 5 days) and 2 classic clinical features (non-exudative conjunctivitis, mucosal changes), raising strong suspicion for incomplete Kawasaki disease. According to American Heart Association (AHA) guidelines, infants with unexplained fever for ≥ 7 days (or high suspicion after 5 days) should undergo laboratory evaluation. This patient's profound systemic inflammation (ESR 85 mm/hr, CRP 120 mg/L) combined with supplemental laboratory findings—anemia, thrombocytosis, leukocytosis, and sterile pyuria—confirms the diagnosis of incomplete Kawasaki disease. Sterile pyuria specifically results from sterile urethritis. The most critical intervention is the immediate administration of intravenous immunoglobulin (IVIG) and high-dose aspirin to reduce systemic vasculitis and prevent the development of coronary artery aneurysms. An echocardiogram should also be ordered, but treatment should not be delayed pending its results.

Step-by-Step Solution

1
Analyze the clinical criteria for Kawasaki disease.
The infant has 6 days of fever but only 2 classic criteria (conjunctivitis, oral changes).
This raises high suspicion for incomplete Kawasaki disease, especially in infants under 6 months who are at the highest risk for developing coronary artery aneurysms.
2
Evaluate the laboratory findings against the American Heart Association (AHA) criteria for incomplete Kawasaki disease.
The patient has markedly elevated inflammatory markers (CRP > 30 mg/L, ESR > 40 mm/hr) and meets 4 supplemental laboratory criteria: anemia, thrombocytosis (Platelets > 450,000/mm³), leukocytosis (WBC > 15,000/mm³), and sterile pyuria (≥ 10 WBC/hpf).
Meeting ≥ 3 supplemental laboratory criteria in the setting of elevated CRP/ESR confirms the diagnosis of incomplete Kawasaki disease.
3
Determine the next best step in management based on the confirmed diagnosis.
Immediate administration of intravenous immunoglobulin (IVIG) and high-dose aspirin is indicated.
Prompt treatment within 10 days of fever onset significantly reduces the risk of developing life-threatening coronary artery aneurysms from 25% to less than 5%.

Key Concept

Diagnosis and management of incomplete Kawasaki disease using supplemental clinical and laboratory criteria.
Rate this question

Topics

Pediatric Cardiovascular Disorders

More questions from this topic